|
1
|
Mikami Y: Cervical cancer. Rinsho Byori.
62:596–604. 2014.(In Japanese). PubMed/NCBI
|
|
2
|
Mirzaie-Kashani E, Bouzari M, Talebi A and
Arbabzadeh-Zavareh F: Detection of human papillomavirus in chronic
cervicitis, cervical adenocarcinoma, intraepithelial neoplasia and
squamus cell carcinoma. Jundishapur J Microbiol.
7:e99302014.PubMed/NCBI
|
|
3
|
Petry KU: Hpv and cervical cancer. Scand J
Clin Lab Invest Suppl. 74:59–62. 2014. View Article : Google Scholar
|
|
4
|
Tobing MD, Sahiratmadja E, Dinda M,
Hernowo BS and Susanto H: Human papillomavirus genotypes profile in
cervical cancer patients at Dr. Hasan Sadikin general hospital,
Bandung, Indonesia. Asian Pac J Cancer Prev. 15:5781–5785. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wen Y, Pan XF, Zhao ZM, Chen F, Fu CJ, Li
SQ, Zhao Y, Chang H, Xue QP and Yang CX: Knowledge of human
papillomavirus (HPV) infection, cervical cancer and HPV vaccine and
its correlates among medical students in Southwest China: A
multi-center cross-sectional survey. Asian Pac J Cancer Prev.
15:5773–5779. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Devergne O, Hummel M, Koeppen H, Le Beau
MM, Nathanson EC, Kieff E and Birkenbach M: A novel interleukin-12
p40-related protein induced by latent Epstein-Barr virus infection
in B lymphocytes. J Virol. 70:1143–1153. 1996.PubMed/NCBI
|
|
7
|
Niedobitek G, Päzolt D, Teichmann M and
Devergne O: Frequent expression of the Epstein-Barr virus
(EBV)-induced gene, Ebi3, an IL-12 p40-related cytokine, in hodgkin
and reed-sternberg cells. J Pathol. 198:310–316. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Larousserie F, Bardel E, Pflanz S, Arnulf
B, Lome-Maldonado C, Hermine O, Brégeaud L, Perennec M, Brousse N,
Kastelein R and Devergne O: Analysis of interleukin-27 (EBI3/p28)
expression in Epstein-barr virus- and human T-cell leukemia virus
type 1-associated lymphomas: Heterogeneous expression of EBI3
subunit by tumoral cells. Am J Pathol. 166:1217–1228. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Larousserie F, Bardel E, Coulomb-L'Herminé
A, Canioni D, Brousse N, Kastelein RA and Devergne O: Variable
expression of Epstein-Barr virus-induced gene 3 during normal
B-cell differentiation and among B-cell lymphomas. J Pathol.
209:360–368. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nishino R, Takano A, Oshita H, Ishikawa N,
Akiyama H, Ito H, Nakayama H, Miyagi Y, Tsuchiya E, Kohno N, et al:
Identification of Epstein-Barr virus-induced gene 3 as a novel
serum and tissue biomarker and a therapeutic target for lung
cancer. Clin Cancer Res. 17:6272–6286. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zeng JC, Zhang Z, Li TY, Liang YF, Wang
HM, Bao JJ, Zhang JA, Wang WD, Xiang WY, Kong B, et al: Assessing
the role of IL-35 in colorectal cancer progression and prognosis.
Int J Clin Exp Pathol. 6:1806–1816. 2013.PubMed/NCBI
|
|
12
|
Gonin J, Larousserie F, Bastard C,
Picquenot JM, Couturier J, Radford-Weiss I, Dietrich C, Brousse N,
Vacher-Lavenu MC and Devergne O: Epstein-Barr virus-induced gene 3
(EBI3): A novel diagnosis marker in Burkitt lymphoma and diffuse
large B-cell lymphoma. PLoS One. 6:e246172011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen C, Peng J, Xia HS, Yang GF, Wu QS,
Chen LD, Zeng LB, Zhang ZL, Pang DW and Li Y: Quantum dots-based
immunofluorescence technology for the quantitative determination of
HER2 expression in breast cancer. Biomaterials. 30:2912–2918. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen C, Xia HS, Gong YP, Peng J, Peng CW,
Hu MB, Zhu XB, Pang DW, Sun SR and Li Y: The quantitative detection
of total HER2 load by quantum dots and the identification of a new
subtype of breast cancer with different 5-year prognosis.
Biomaterials. 31:8818–8825. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Poleganov MA, Bachmann M, Pfeilschifter J
and Mühl H: Genome-wide analysis displays marked induction of
EBI3/IL-27B in IL-18-activated AML-derived KG1 cells: Critical role
of two kappaB binding sites in the human EBI3 promotor. Mol
Immunol. 45:2869–2880. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Collison LW, Workman CJ, Kuo TT, Boyd K,
Wang Y, Vignali KM, Cross R, Sehy D, Blumberg RS and Vignali DA:
The inhibitory cytokine IL-35 contributes to regulatory T-cell
function. Nature. 450:566–569. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Collison LW, Pillai MR, Chaturvedi V and
Vignali DA: Regulatory T cell suppression is potentiated by target
T cells in a cell contact, IL-35-and IL-10-dependent manner. J
Immunol. 182:6121–6128. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Collison LW, Chaturvedi V, Henderson AL,
Giacomin PR, Guy C, Bankoti J, Finkelstein D, Forbes K, Workman CJ,
Brown SA, et al: IL-35-mediated induction of a potent regulatory T
cell population. Nat Immunol. 11:1093–1101. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Seyerl M, Kirchberger S, Majdic O, Seipelt
J, Jindra C, Schrauf C and Stöckl J: Human rhinoviruses induce
IL-35-producing Treg via Induction of B7-H1 (CD274) and
sialoadhesin (CD169) on DC. Eur J Immunol. 40:321–329. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chaturvedi V, Collison LW, Guy CS, Workman
CJ and Vignali DA: Cutting edge: Human regulatory T cells require
IL-35 to mediate suppression and infectious tolerance. J Immunol.
186:6661–6666. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li X, Mai J, Virtue A, Yin Y, Gong R, Sha
X, Gutchigian S, Frisch A, Hodge I, Jiang X, et al: IL-35 is a
novel responsive anti-inflammatory cytokine-a new system of
categorizing anti-inflammatory cytokines. PLoS One. 7:e336282012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Long J, Zhang X, Wen M, Kong Q, Lv Z, An Y
and Wei XQ: IL-35 over-expression increases apoptosis sensitivity
and suppresses cell growth in human cancer cells. Biochem Biophys
Res Commun. 430:364–369. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Devergne O, Birkenbach M and Kieff E:
Epstein-Barr virus-induced gene 3 and the p35 subunit of
interleukin 12 form a novel heterodimeric hematopoietin. Proc Natl
Acad Sci USA. 94:12041–12046. 1997. View Article : Google Scholar : PubMed/NCBI
|
